LYNSEY RATHER: Open Payments
NPI 1518634245 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 49 payments from 9 companies in 2025. Trend: 2023 $1,172 · 2024 $888 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 26 | $291 |
| UCB, Inc. | 12 | $186 |
| Radius Health, Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| Actelion Pharmaceuticals US, Inc. | 2 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Organon LLC | 1 | $12 |
Products named: Bimzelx, TAVNEOS, KRYSTEXXA, EVENITY, Tymlos, BENLYSTA, OPSYNVI, OFEV.
Industry payments across TX — which companies pay providers there.
